Early experience with therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease

被引：0
|
作者：
Fernandez, R. [1 ]
Sanchez, G. [1 ]
Pedraza, L. [1 ]
Prieto, V. [2 ]
Calabuig, V. K. [2 ]
Fernandez, E. [1 ]
Otero, M. J. [1 ]
机构：
[1] Complejo Asistencial Univ Salamanca, Hosp Pharm, Salamanca, Spain
[2] Complejo Asistencial Univ Salamanca, Digest Unit, Salamanca, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2019年 / 41卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
TDMP003
引用
收藏
页码：361 / 362
页数：2
相关论文
共 50 条
  • [21] Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment-TUMMY Study
    Sivridas, Merve
    Creemers, Rob H.
    Wong, Dennis R.
    Boekema, Paul J.
    Romkens, Tessa E. H.
    Gilissen, Lennard P. L.
    van Bodegraven, Adriaan A.
    Loeff, Floris C.
    Rispens, Theo
    Derijks, Luc J. J.
    PHARMACEUTICS, 2023, 15 (03)
  • [22] Therapeutic Drug Monitoring of Adalimumab in Patients With Inflammatory Bowel Disease
    El-Matary, Wael
    CROHNS & COLITIS 360, 2019, 1 (03)
  • [23] Therapeutic drug monitoring in patients with inflammatory bowel disease on ustekinumab
    Saleh, Adam
    Stading, Rachel
    Miroballi, Natalia
    Glassner, Kerri
    Abraham, Bincy P.
    JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (04) : 214 - 221
  • [24] Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?
    Alsoud, Dahham
    Vermeire, Severine
    Verstockt, Bram
    CURRENT OPINION IN PHARMACOLOGY, 2020, 55 : 17 - 30
  • [25] Therapeutic drug monitoring in inflammatory bowel disease
    Kopylov, Uri
    Ben-Horin, Shomron
    Seidman, Ernest
    ANNALS OF GASTROENTEROLOGY, 2014, 27 (04): : 304 - 312
  • [26] Therapeutic drug monitoring in inflammatory bowel disease
    Jossen, Jacqueline
    Dubinsky, Marla
    CURRENT OPINION IN PEDIATRICS, 2016, 28 (05) : 620 - 625
  • [27] Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring
    Wiken, Thea H.
    Hoivik, Marte L.
    Buer, Lydia
    Warren, David J.
    Bolstad, Nils
    Moum, Bjorn A.
    Anisdahl, Karoline
    Smastuen, Milada C.
    Medhus, Asle W.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, : 863 - 873
  • [28] Experience with therapeutic drug monitoring on adalimumab in paediatric inflammatory bowel disease (pIBD)
    Sider, S.
    Cococcioni, L.
    ElZein, A.
    Chadokufa, S.
    Buckingham, R.
    Shah, N.
    Ocholi, A.
    Borrelli, O.
    Kiparissi, F.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S566 - S566
  • [29] IMPACT OF THERAPEUTIC DRUG MONITORING ON OUTCOMES FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hussenbux, Arif
    Chopra, Tanya
    Stearns, Rebecca
    Ravindran, Rahul
    Patodi, Nishant
    De Silva, Aminda
    GUT, 2021, 70 : A100 - A100
  • [30] OUTCOMES OF DOSE ESCALATION AND DRUG LEVEL MONITORING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Scoville, Elizabeth A.
    Izmaylov, Michelle L.
    Bennett, Audrey
    Evers, Lauren
    Annis, Kim
    Garrett, Ailish
    Duley, Caroline
    Adams, Dawn W.
    Dalal, Robin L.
    Beaulieu, Dawn
    Schwartz, David A.
    Horst, Sara N.
    GASTROENTEROLOGY, 2018, 154 (06) : S829 - S830
12345